Komori
General Meetings of Shareholders4886ASKA Pharmaceutical Holdings Co.,Ltd.Pharmaceuticals

Matters Subject to Electronic Provision in Connection with the Notice of Convocation of the 5th Annual General Meeting of Shareholders

The Company will provide electronically the status of internal control operations, consolidated notes and non-consolidated notes that were omitted from the notice of convocation of the 5th Annual General Meeting of Shareholders in the paper documents.

Worth reading
—
Scored from 0 of 4 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (5th)
2026
Jun 24
Date and time(start time: Not disclosed)28 days from this disclosure to the meeting
Matters for resolution1 item
  1. Disposition of surplus (proposal title and number: Not disclosed)

Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (5th)
Date and time24 June 2026 (start time: Not disclosed)
Matters for resolutionDisposition of surplus (proposal title and number: Not disclosed)
Items this document does not state (3)
Shareholder ProposalDirector nomineePercentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because their inclusion in the documents delivered to shareholders who requested delivery of paper documents is omitted pursuant to applicable laws and regulations and Article 16 of the Articles of Incorporation.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Matters Subject to Electronic Provision in Connection with the Notice of Convocation of the 5th Annual General Meeting of Shareholders | ASKA Pharmaceutical Holdings Co.,Ltd. (4886) timely disclosure | Komori